開発業務受託機関市場 - 世界の産業規模、シェア、動向、機会、予測、サービス別、用途別、地域別、競合別、2020年～2030年

開発業務受託機関の世界市場は、2024年に521億5,000万米ドルと評価され、2030年までには681億5,000万米ドルに達し、CAGR4.76％で成長すると予測されています。

医薬品開発に関連する複雑さ、コスト、規制の精査の増加は、市場開拓の主な要因となっています。製薬企業やバイオテクノロジー企業は、国際的な規制の枠組みを遵守しながら開発期間を短縮し、費用を管理しなければならないというプレッシャーに直面しています。これを達成するため、多くの企業が臨床および前臨床研究機能をCROにアウトソーシングしています。CROは専門的な専門知識、グローバルインフラ、最先端の技術を提供しています。CROは、開発ワークフローの合理化、コンプライアンスの管理、研究活動の拡張性の実現において極めて重要な役割を果たしています。しかし、競合からの圧力、地域ごとに進化する競合情勢、厳格なデータインテグリティとGCP（医薬品の臨床試験の実施の基準）遵守の必要性によって、市場の成長は抑制されています。このような課題にもかかわらず、CROは世界化が進む製薬業界において、費用対効果が高く効率的な研究サービスを提供する戦略的パートナーであり続けています。

主要な市場促進要因

ヘルスケア産業の成長

主要な市場課題

臨床試験コストの上昇

主要市場動向

バイオシミラーと生物製剤の臨床試験の増加

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の開発業務受託機関市場にCOVID-19が与える影響

第5章 世界の開発業務受託機関市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サービス別（初期段階の開発サービス、臨床調査サービス、ラボサービス、コンサルティングサービス、データ管理サービス）
  • 用途別（腫瘍学、中枢神経系、心血管系、呼吸器系、感染症、自己免疫疾患、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の開発業務受託機関市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の開発業務受託機関市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の開発業務受託機関市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の開発業務受託機関市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの開発業務受託機関市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界の開発業務受託機関市場：SWOT分析

第15章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第16章 競合情勢

• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• PerkinElmer Inc.
• Standard BioTools Inc.
• Illumina, Inc.
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Contract Research Organization Market was valued at USD 52.15 Billion in 2024 and is projected to reach USD 68.15 Billion by 2030, growing at a CAGR of 4.76%. The increasing complexity, cost, and regulatory scrutiny associated with drug development are key factors fueling the market's growth. Pharmaceutical and biotechnology companies are facing mounting pressure to accelerate development timelines and manage expenses while complying with global regulatory frameworks. To achieve this, many are outsourcing clinical and preclinical research functions to CROs, which offer specialized expertise, global infrastructure, and cutting-edge technologies. CROs play a pivotal role in streamlining development workflows, managing compliance, and enabling scalability in research efforts. However, market growth is tempered by competitive pressures, evolving regulatory landscapes across regions, and the need for stringent data integrity and Good Clinical Practice (GCP) compliance. Despite these challenges, CROs continue to be strategic partners in delivering cost-effective and efficient research services across an increasingly globalized pharmaceutical landscape.

Key Market Drivers

Growth in Healthcare Industry

The rapid expansion of the global healthcare industry is a major driver of the Contract Research Organization market. Rising investments in biopharmaceutical R&D, increasing focus on personalized medicine, and an expanding portfolio of therapeutic innovations are prompting pharmaceutical and medical device companies to seek external support from CROs. Countries such as Finland, Belgium, and Japan are leading with highly efficient healthcare systems, while even advanced markets like the U.S. face ongoing challenges in cost and care accessibility. With millions remaining uninsured and healthcare systems under pressure, pharmaceutical companies are leveraging CROs to improve efficiency and minimize development risks. CROs offer a range of services-spanning early-stage discovery to post-market surveillance-that help sponsors navigate complex clinical and regulatory environments. As healthcare demands rise, so does the need for efficient outsourcing solutions that CROs are well-positioned to provide.

Key Market Challenges

Rising Cost of Clinical Trials

Escalating costs associated with conducting clinical trials present a significant challenge for the CRO industry. As trial protocols become more complex, involving diverse geographies, larger patient populations, and advanced data requirements, the financial burden on sponsors and service providers increases. Additional costs stem from the integration of high-end technologies, including biomarker analysis, genomic profiling, and real-time data monitoring tools-all of which require significant investment in infrastructure and expertise. Logistical complexities associated with managing global trial sites and ensuring regulatory compliance across jurisdictions add further operational strain. For CROs, balancing cost-efficiency with quality service delivery remains a critical concern, particularly when servicing cost-sensitive clients or navigating budget constraints in emerging markets.

Key Market Trends

Rise in Biosimilars and Biologics Trials

The expanding focus on biosimilars and biologics is reshaping the global CRO landscape. The expiration of patents on high-value biologic drugs has opened opportunities for biosimilar development, especially in markets like India that offer cost-effective research ecosystems and supportive regulatory structures. India is increasingly recognized as a preferred location for biosimilar trials due to its skilled workforce and favorable clinical infrastructure. Meanwhile, the rise of complex biologics-including monoclonal antibodies, vaccines, and gene therapies-requires specialized research capabilities. CROs equipped to handle bioanalytical testing, immunogenicity evaluation, and biomarker analysis are in high demand as sponsors look for end-to-end biologics expertise. This trend reflects a broader shift toward advanced therapies and precision medicine, with CROs playing a vital role in accelerating development and navigating the regulatory complexities of modern biologics.

Key Market Players

• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• PerkinElmer Inc.
• Standard BioTools Inc.
• Illumina, Inc.
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V.

Report Scope

In this report, the Global Contract Research Organization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contract Research Organization Market, By Service:

• Early Phase Development Services
• Clinical Research Services
• Laboratory Services
• Consulting Services
• Data Management Services

Contract Research Organization Market, By Application:

• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Infectious Diseases
• Autoimmune Disorders
• Others

Contract Research Organization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contract Research Organization Market.

Available Customizations

Global Contract Research Organization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Contract Research Organization Market

5. Global Contract Research Organization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services)
  • 5.2.2. By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Contract Research Organization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contract Research Organization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Contract Research Organization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Contract Research Organization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Application

7. Europe Contract Research Organization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Contract Research Organization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Contract Research Organization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Contract Research Organization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Contract Research Organization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Contract Research Organization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Application

8. Asia Pacific Contract Research Organization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contract Research Organization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Application
  • 8.3.2. India Contract Research Organization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Contract Research Organization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Contract Research Organization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Contract Research Organization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Application

9. South America Contract Research Organization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Contract Research Organization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Contract Research Organization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Contract Research Organization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Application

10. Middle East and Africa Contract Research Organization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Contract Research Organization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Contract Research Organization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Contract Research Organization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Contract Research Organization Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. GE HealthCare Technologies Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Abbott Laboratories
• 16.3. Agilent Technologies, Inc.
• 16.4. PerkinElmer Inc.
• 16.5. Standard BioTools Inc.
• 16.6. Illumina, Inc.
• 16.7. Bio-Rad Laboratories Inc.
• 16.8. Cepheid Inc.
• 16.9. Thermo Fisher Scientific, Inc.
• 16.10. Qiagen N.V.

17. Strategic Recommendations

18. About Us & Disclaimer